NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: Role of nitric oxide

Circulation

Volumn 106, Issue 24, 2002, Pages 3120-3125

  Fiorucci, Stefano ^a   Mencarelli, Andrea ^a   Meneguzzi, Alessandra ^b   Lechi, Alessandro ^b   Morelli, Antonio ^a   Del Soldato, Piero ^c,d   Minuz, Pietro ^b,e  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c NicOx SA   (France)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e Medicina Interna C   (Italy)

Author keywords

Aspirin; Nitric oxide; Platelets; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; ISOSORBIDE MONONITRATE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME INHIBITION; FLOW CYTOMETRY; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINALYSIS; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOTTING, WESTERN; CYCLOOXYGENASE 2; CYSTEINE PROTEINASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FLOW CYTOMETRY; GASTRIC MUCOSA; INTERLEUKIN-1; ISOENZYMES; ISOSORBIDE DINITRATE; MALE; MONOCYTES; NITRIC OXIDE; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOPLASTIN; THROMBOXANE B2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037058876     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000039341.57809.1E     Document Type: Article

References (35)

1. Franco RF, de Jonge E, Dekkers PE, et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation. Blood. 2000;96:554-559.
2. Lwaleed BA, Bass PS, Cooper AJ. The biology and tumour-related properties of monocyte tissue factor. J Pathol. 2001;193:3-12.
3. Morrissey JH. Tissue factor: An enzyme cofactor and a true receptor. Thromb Haemost. 2001;86:66-74.
4. Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 1994;93:391-396.
5. Ross R, Atherosclerosis: An inflammatory disease. N Engl J Med. 1999; 340:115-126.
6. Toschi V, Gallo R, Lettino M, et al. Tissue factor modulates the thrombogenicity of haman atherosclerotic plaques. Circulation. 1997;95: 594-599.
7. Patrono C, Patrignani P, Garcia Rodriguez LA. Cyclooxygenase-selective inhibition of prostanoid formation: Transducing biochemical selectivity into clinical read-outs. J Clin Invest. 2001;108:7-13.
8. Lecomte M, Laneuville O, Ji C, et al. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 1994;269:13207-13215.
9. Pernerstorfer T, Stohlawetz P, Hollenstein U, et al. Endotoxin-induced activation of the coagulation cascade in humans: Effect of acetylsalicylic acid and acetaminophen. Arterioscler Thromb Vasc Biol. 1999;19: 2517-2523.
10. Osnes LT, Foss KB, Joo GB, et al. Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-ReI nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. Thromb Haemost. 1996;76:970-976.
11. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: An overview. Circ Res. 2002;90:21-28.
12. Fiorucci S, Antonelli E, Mencarelli A, et al. A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway. Br J Pharmacol. 2002;135:589-599.
13. Momi S, Emerson M, Paul W, et al. Prevention of pulmonary thrombo-embolism by NCX 4016, a nitric oxide-releasing aspirin [In Process Citation]. Eur J Pharmacol. 2000;397:177-185.
14. Rossoni G, Manfredi B, Colonna VD, et al. The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat. J Pharmacol Exp Ther. 2001;297: 380-387.
15. Napoli C, Cirino G, Del Soldato P, et al. Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A. 2001;98:2860-2864.
16. Langford EJ, Brown AS, Wainwright RJ, et al. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 1994;344:1458-1460.
17. Lechi C, Andrioli G, Gaino S, et al. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid: An in vitro study of inhibition on the early phase of platelet activation and on TXA2 production. Thromb Haemost. 1996;76:791-798.
18. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res. 2001;88:756-762.
19. Fiorucci S, Santucci L, Cirino G, et al. IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: New insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol. 2000;165:5245-5254.
20. Minuz P, Degan M, Gaino S, et al. NCX4016 (NO-aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. Br J Pharmacol. 2001;134:905-911.
21. Cuzzolin L, Adami A, Degan M, et al. Effect of single and repeated doses of a new nitroderivative of acetylsalicylic acid on platelet TXA2 production in rats. Life Sci. 1996;58:L207-L210.
22. Watanabe T, Yasuda M, Yamamoto T. Angiogenesis induced by tissue factor in vitro and in vivo. Thromb Res. 1999;96:183-189.
23. Fiorucci S, Antonelli E, Santucci L, et al. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology. 1999;116:1089-1106.
24. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992;90: 1718-1725.
25. Corseaux D, Le Tourneau T, Six I, et al. Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: Inhibition with dietary L-arginine. Circulation. 1998;98: 1776-1782.
26. Yang Y, Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation. 2000;101: 2144-218.
27. Oeth P, Parry GC, Mackman N. Regulation of the tissue factor gene in human monocytic cells: Role of AP-1, NF-kappa B/ReI, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol. 1997;17:365-374.
28. Swierkosz TA, Mitchell JA, Warner TD, et al. Co-induction of nitric oxide synthase and cyclo-oxygenase: Interactions between nitric oxide and prostanoids. Br J Pharmacol. 1995;114:1335-1342.
29. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
30. Osterud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: Requirement of platelets and granulocytes. J Leukoc Biol. 1992;51:462-465.
31. Celi A, Pellegrini G, Lorenzet R, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA. 1994;91: 8767-8771.
32. Senaldi G, Piguet PF. Mortality and platelet depletion occur independently of fibrinogen consumption in murine models of tumour necrosis factor-mediated systemic inflammatory responses. Cytokine. 1998;10: 382-389.
33. McAdam BF, Mardini IA, Habib A, et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest. 2000;105:1473-1482.
34. Fiorucci S, Santucci L, Antonelli E, et al. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology. 2000;118:404-421.
35. Oltrona L, Speidel CM, Recchia D, et al. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation 1997;96:646-652.